De-Escalation Study Evaluating Venetoclax and Azacitidine Discontinuation in AML Responding Patients

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
De-Escalation Study Evaluating Venetoclax and Azacitidine Discontinuation in AML Responding Patients	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Recruiting	Phase 2	2026-03-13		NCT06557421

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Institut Paoli-Calmettes	60

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Institut Paoli-Calmettes	Marseille	France	19

Clinical trials